German biotech Repairon, which is developing regenerative cardiac therapies, today announced the appointment of Detlef ...

Germany’s Merck KGaA today announced its entry into a definitive agreement to acquire Silence Therapeutics, sending the ...

China's Hansoh Pharma has signed a strategic collaboration and license agreement with Swiss pharma giant Roche to develop a ...

Danish clinical-stage techbio company Evaxion, which is developing novel immunotherapies with its pioneering AI-Immunology platform, announced new three-year clinical outcome data for personalized ...

Vancouver-based biotech Zymeworks has appointed Suzanne Monahan as senior vice president, commercial, and general manager of ...

Hungary’s largest drugmaker Gedeon Richter announced that the US Food and Drug Administration (FDA) has accepted for review ...

Scenic Biotech is preparing to take its lead program, SC6177, into clinical development in 2027. The Pharma Letter speaks ...

Shares of US dermatologist-founded Veradermics were up 8.4% at $118.00 pre-market on positive clinical results for its hair ...

French pharma major Sanofi today broke ground on a new state-of-the-art insulin manufacturing facility at its BioCampus in Frankfurt, Germany.

Swiss radiopharmaceutical company Nuclidium has entered a long-term partnership with NorthStar Medical Technologies, under ...

Swiss clinical-stage, cancer interception focused biotech Nouscom today announced the closing of an oversubscribed 120 million euros ($135 million) Series D financing.

French biotech company OSE Immunotherapeutics (Euronext Paris: OSE) has reported Phase II results showing higher one-year ...